First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Updated: May 17, 2024

Vifor Pharma AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Research & Development Peer Comparison

Comparables:
NOVN
NLSP
ROG
S
SDZ

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Research & Development
-CHf212.5m
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Research & Development
-$10.8B
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
-2%
NLS Pharmaceutics AG
NASDAQ:NLSP
Research & Development
-$9m
CAGR 3-Years
-74%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Roche Holding AG
SIX:ROG
Research & Development
-CHf13.2B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
S
Sandoz Group AG
SIX:SDZ
Research & Development
-$831m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Research & Development?
Research & Development
-212.5m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Research & Development amounts to -212.5m CHF.

What is Vifor Pharma AG's Research & Development growth rate?
Research & Development CAGR 5Y
-12%

Over the last year, the Research & Development growth was 15%. The average annual Research & Development growth rates for Vifor Pharma AG have been -1% over the past three years , -12% over the past five years .